Hence, the FVIII activity, an important activation marker of the haemostatic system, was significantly increased in the plasma of patients with lung cancer (Table 1; FC = 1.75; p = 0.0002) and to a lesser extent in patients with brain cancer (Table 1; FC = 1.26; p = 0.001). This evidence concerns the gene F8 and lung carcinoma.